These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12184028)

  • 1. [Dual role of nitric oxide in the pathogenesis of diabetic nephropathy].
    Ksiazek K; Witowski J
    Przegl Lek; 2002; 59(3):153-7. PubMed ID: 12184028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production.
    Prabhakar S; Starnes J; Shi S; Lonis B; Tran R
    J Am Soc Nephrol; 2007 Nov; 18(11):2945-52. PubMed ID: 17928507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of nitric oxide synthase in the diabetic rabbit kidney: potential relevance to the early pathogenesis of diabetic nephropathy.
    Mumtaz FH; Dashwood MR; Khan MA; Thompson CS; Mikhailidis DP; Morgan RJ
    Curr Med Res Opin; 2004 Jan; 20(1):1-6. PubMed ID: 14741064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of TGF-beta in pathogenesis of diabetic nephropathy.
    Pantsulaia T
    Georgian Med News; 2006 Feb; (131):13-8. PubMed ID: 16575121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of nitric oxide in diabetic nephropathy.
    Prabhakar SS
    Semin Nephrol; 2004 Jul; 24(4):333-44. PubMed ID: 15252773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tranilast prevents the progression of experimental diabetic nephropathy through suppression of enhanced extracellular matrix gene expression.
    Akahori H; Ota T; Torita M; Ando H; Kaneko S; Takamura T
    J Pharmacol Exp Ther; 2005 Aug; 314(2):514-21. PubMed ID: 15857946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncoupling of VEGF with NO as a mechanism for diabetic nephropathy.
    Nakagawa T
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S67-9. PubMed ID: 18926584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial dysfunction: a tug of war in diabetic nephropathy?
    Balakumar P; Chakkarwar VA; Krishan P; Singh M
    Biomed Pharmacother; 2009 Mar; 63(3):171-9. PubMed ID: 18823739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can rodent models of diabetic kidney disease clarify the significance of early hyperfiltration?: recognizing clinical and experimental uncertainties.
    Levine DZ
    Clin Sci (Lond); 2008 Jan; 114(2):109-18. PubMed ID: 18062776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide in diabetic nephropathy.
    Craven PA; DeRubertis FR; Melhem M
    Kidney Int Suppl; 1997 Sep; 60():S46-53. PubMed ID: 9285902
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal oxidative stress and nitric oxide production in streptozotocin-induced diabetic nephropathy in rats: the possible modulatory effects of garlic (Allium sativum L.).
    Mariee AD; Abd-Allah GM; El-Yamany MF
    Biotechnol Appl Biochem; 2009 Mar; 52(Pt 3):227-32. PubMed ID: 18588510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pravastatin modulates early diabetic nephropathy in an experimental model of diabetic renal disease.
    Casey RG; Joyce M; Roche-Nagle G; Chen G; Bouchier-Hayes D
    J Surg Res; 2005 Feb; 123(2):176-81. PubMed ID: 15680375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of diabetic nephropathy: involvement of multifaceted signalling mechanism.
    Balakumar P; Arora MK; Reddy J; Anand-Srivastava MB
    J Cardiovasc Pharmacol; 2009 Aug; 54(2):129-38. PubMed ID: 19528810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The renin-angiotensin system and diabetic nephropathy.
    Gurley SB; Coffman TM
    Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy.
    Nakagawa T; Sato W; Glushakova O; Heinig M; Clarke T; Campbell-Thompson M; Yuzawa Y; Atkinson MA; Johnson RJ; Croker B
    J Am Soc Nephrol; 2007 Feb; 18(2):539-50. PubMed ID: 17202420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic nephropathy: nitric oxide and renal medullary hypoxia.
    Pollock JS; Carmines PK
    Am J Physiol Renal Physiol; 2008 Jan; 294(1):F28-9. PubMed ID: 18003855
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of endothelin-1 and nitric oxide in the pathogenesis of hypertension in diabetic patients.
    Tomić M; Galesić K; Morović-Vergles J; Romić Z; Mikulić I
    Coll Antropol; 2008 Mar; 32(1):93-8. PubMed ID: 18496905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered contractile response due to increased beta3-adrenoceptor stimulation in diabetic cardiomyopathy: the role of nitric oxide synthase 1-derived nitric oxide.
    Amour J; Loyer X; Le Guen M; Mabrouk N; David JS; Camors E; Carusio N; Vivien B; Andriantsitohaina R; Heymes C; Riou B
    Anesthesiology; 2007 Sep; 107(3):452-60. PubMed ID: 17721248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy.
    Hohenstein B; Hugo CP; Hausknecht B; Boehmer KP; Riess RH; Schmieder RE
    Nephrol Dial Transplant; 2008 Apr; 23(4):1346-54. PubMed ID: 18065828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical-molecular markers in unilateral ureteral obstruction.
    Manucha W
    Biocell; 2007; 31(1):1-12. PubMed ID: 17665634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.